JAK inhibitor in omalizumab unresponsive chronic Rhinosinusitis with nasal polyposis patient, as an add on therapy, the first case series in human

World Allergy Organization Journal 2026 Open access

Read full text

Authors: Morteza Fallahpour, Mohammad Nabavi, Babak Ghalebaghi, Mohammad Hasan Bemanian, Maryam Jalesi

DOI: 10.1016/j.waojou.2026.101259

Cited by: 0

Fields of Study & Subjects

Sinusitis and nasal conditions Immunodeficiency and Autoimmune Disorders Cystic Fibrosis Research Advances